To operate a rapid health technology assessment for treatment of endometriosis with dienogest, providing evidence for clinical evaluation and decision-making.
The researches of dienogest on endometriosis were searched in Pubmed, Embase, CNKI, Wanfang and other databases. AMSTAR, OQAQ and CHEERS (2022) were used to evaluate the methodological quality of health economics, and the treatment of endometriosis with dienogest was comprehensive evaluated.
The comprehensive evaluation results showed that dienogest had obvious advantages in preventing recurrence rate and improving pain after endometriosis surgery compared with expectant treatment, and was comparable to gonadotrophin releasing hormone analogue (GnRH-a). On safety evaluation, compared with other therapeutic drugs, dienogest had a higher risk of vaginal bleeding, and the risk of headache and weight gain also should be noted, while the risk of hot flashes, vaginal dryness and osteoporosis was relatively small. From perspective of medical insurance payment, dienogest was more cost-effective compared with GnRH-a, but had no advantage compared with combined oral contraceptives (COC).
Dienogest could be used as a long-term maintenance treatment after endometriosis surgery. However, compared with other treatments such as GnRH-a and COC, the efficacy, safety, and pharmacoeconomics of dienogest should be further explored.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |